二叶式与三叶式主动脉瓣狭窄患者SAVR术后传导障碍及预后比较
该队列研究纳入1147例术前无传导障碍的孤立SAVR患者,比较BAV-AS与TAV-AS术后新发三度AVB和LBBB的发生率及预后。BAV-AS患者新发三度AVB(6.5% vs 2.5%,P=0.001)和新发LBBB(9.7% vs 5.7%,P=0.013)均高于TAV-AS,新发LBBB与随访期全因死亡率升高相关(aHR 1.60,95%CI 1.12-2.30,P=0.011)。右冠瓣与无冠瓣融合的BAV亚型风险最高。
要点
- BAV-AS患者SAVR术后新发三度AVB和LBBB风险均高于TAV-AS患者。
- 新发LBBB与随访期全因死亡率升高独立相关,而新发三度AVB未显示预后关联。
- 右冠瓣与无冠瓣融合的BAV亚型术后传导障碍风险最高。
核心结论
- SAVR术后新发LBBB与随访期全因死亡率升高相关。
- BAV-AS患者较TAV-AS患者更易发生术后新发三度AVB和LBBB。
- 右冠瓣与无冠瓣融合的BAV亚型术后传导障碍风险最高。
研究设计与样本
- 队列研究,纳入2005年1月1日至2022年12月31日连续1147例术前无传导障碍、接受孤立SAVR(伴或不伴升主动脉手术)的患者。
- 按主动脉瓣形态分层:BAV组n=589,TAV组n=558;BAV形态按Sievers和Schmidtke分类可在307例BAV-AS患者中进一步分型。
- 主要结局为住院期间新发三度AVB或新发LBBB,并随访中位8.2年评估其对生存的影响。
主要发现
- SAVR术后总体新发三度AVB发生率为4.5%,新发LBBB发生率为7.8%。
- BAV-AS组新发三度AVB发生率6.5% vs TAV-AS组2.5%(P=0.001)。
- BAV-AS组新发LBBB发生率9.7% vs TAV-AS组5.7%(P=0.013)。
- 新发LBBB与随访期全因死亡率升高相关(校正HR 1.60,95%CI 1.12-2.30;P=0.011),新发三度AVB与预后无关。
- 以TAV为参照,右冠瓣与无冠瓣融合的BAV亚型新发三度AVB的aOR为8.33(95%CI 3.31-20.97,P<0.001),新发LBBB的aOR为4.03(95%CI 1.84-8.82,P<0.001);其他BAV亚型无显著关联。
临床怎么用
- BAV-AS患者SAVR围术期应加强传导障碍监测,尤其关注新发LBBB。
- 对右冠瓣与无冠瓣融合的BAV亚型患者,术前应评估术后传导障碍高风险并个体化制定管理策略。
- 术后新发LBBB患者需重视长期随访和预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aortic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) aortic stenosis (AS) versus patients with tricuspid aortic valve (TAV) AS (ie, BAV-AS and TAV-AS, respectively). Additionally, the study included stratification of BAV patients according to subtype. METHODS: In this cohort study, the incidence of postoperative third-degree atrioventricular (AV) block with subsequent permanent pacemaker requirement and new-onset left bundle-branch block (LBBB) was investigated in 1147 consecutive patients without preoperative conduction disorder who underwent isolated SAVR (with or without ascending aortic surgery) between January 1, 2005, and December 31, 2022. The groups were stratified by aortic valve morphology (BAV, n=589; TAV, n=558). The outcomes of interests were new-onset third-degree AV block or new-onset LBBB during the index hospitalization. The impact of new-onset postoperative conduction disturbances on survival was investigated in BAV-AS and TAV-AS patients during a median follow-up of 8.2 years. BAV morphology was further categorized according to the Sievers and Schmidtke classification system (possible in 307 BAV-AS patients) to explore association between BAV subtypes and new-onset conduction disturbances after SAVR. RESULTS: The overall incidence of third-degree AV block and new-onset LBBB after SAVR was 4.5% and 7.8%, respectively. BAV-AS patients had a higher incidence of both new-onset third-degree AV block (6.5% versus 2.5%; P=0.001) and new-onset LBBB (9.7% versus 5.7%; P=0.013) compared with TAV-AS patients. New-onset LBBB was associated with an increased all-cause mortality during follow-up (adjusted hazard ratio, 1.60 [95% CI, 1.12-2.30]; P=0.011), whereas new-onset third-degree AV block was not associated with worse prognosis. Subgroup analysis of the BAV cohort revealed that BAV-AS patients with fusion of the right- and non-coronary cusps had the highest risk of new-onset third-degree AV block (adjusted odds ratio [aOR], 8.33 [95% CI, 3.31-20.97]; P<0.001, with TAV as reference group) and new-onset LBBB (aOR, 4.03 [95% CI, 1.84-8.82]; P<0.001, with TAV as reference group), whereas no significant association was observed for the other BAV subtypes. CONCLUSIONS: New-onset LBBB after SAVR is associated with increased all-cause mortality during follow-up, and is more frequent complication in BAV AS patients compared with TAV-AS patients. BAV-AS patients with fusion of the right- and non-coronary cusps have an increased risk for conduction disturbances after SAVR. This should be taken into consideration when managing these patients.
引用
- Wedin JO, Näslund V, Rodin S, et al. Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis. Circulation. 2024. PMID: 39440421. doi:10.1161/CIRCULATIONAHA.124.070753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。